SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-193810
Filing Date
2017-06-05
Accepted
2017-06-05 09:16:04
Documents
5
Period of Report
2017-06-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d287164d8k.htm 8-K 13401
2 EX-99.1 d287164dex991.htm EX-99.1 9523
3 EX-99.2 d287164dex992.htm EX-99.2 13659
4 GRAPHIC g287164g44m97.jpg GRAPHIC 2966
5 GRAPHIC g287164page1nn.jpg GRAPHIC 120503
  Complete submission text file 0001193125-17-193810.txt   208132
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 17890057
SIC: 8731 Services-Commercial Physical & Biological Research